On February 18, 2026, Aptevo Therapeutics Inc. held a Special Meeting of Stockholders where they voted on three proposals: the amendment to their Certificate of Incorporation was rejected, the issuance of stock under a Standby Equity Purchase Agreement was approved, and the meeting adjournment was also approved. The vote results showed 273,162 against and 61,044 for the first proposal, with more than 83,000 in favor of the second proposal.